Guidelines for radioiodine therapy of differentiated thyroid cancer von Luster, M., Clarke, S. E., Dietlein, M., Lassmann, M., Lind, P., Oyen, W. J. G., Tennvall, J., Bombardieri, E.

Volltext

Radiofrequency ablation for autonomously functioning nodules as treatment for hyperthyroidism: subgroup analysis of toxic adenoma and multinodular goitre and predictors for treatme... von van der Meeren, M. M. D., Joosten, F. B. M., Roerink, S. H. P. P., Deden, L. N., Oyen, W. J. G.

Volltext

[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer von van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C. T., Dekker, H., van Dongen, G. A. M. S., Vugts, D. J., Boellaard, R., van Herpen, C. M. L., de Vries, E. G. E., Oyen, W. J. G., Brouwers, A. H., Verheul, H. M. W., Hoekstra, O. S., Menke-van der Houven van Oordt, C. W.

Volltext

Targeted Radionuclide and Fluorescence Dual-modality Imaging of Cancer: Preclinical Advances and Clinical Translation von Lütje, S., Rijpkema, M., Helfrich, W., Oyen, W. J. G., Boerman, O. C.

Volltext

Cost-Effectiveness of FDG-PET/CT for Cytologically Indeterminate Thyroid Nodules: A Decision Analytic Approach von Vriens, D, Adang, E. M. M, Netea-Maier, R. T, Smit, J. W. A, de Wilt, J. H. W, Oyen, W. J. G, de Geus-Oei, L. F

Volltext

Anti-CEA Antibody Fragments Labeled with [18F]AlF for PET Imaging of CEA-Expressing Tumors von Lütje, S, Franssen, G. M, Sharkey, R. M, Laverman, P, Rossi, E. A, Goldenberg, D. M, Oyen, W. J. G, Boerman, O. C, McBride, W. J

Volltext

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer von Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J.H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., Ciardiello, F., D'Hoore, A., Diaz-Rubio, E., Douillard, J.-Y., Ducreux, M., Falcone, A., Grothey, A., Gruenberger, T., Haustermans, K., Heinemann, V., Hoff, P., Köhne, C.-H., Labianca, R., Laurent-Puig, P., Ma, B., Maughan, T., Muro, K., Normanno, N., Österlund, P., Oyen, W.J.G., Papamichael, D., Pentheroudakis, G., Pfeiffer, P., Price, T.J., Punt, C., Ricke, J., Roth, A., Salazar, R., Scheithauer, W., Schmoll, H.J., Tabernero, J., Taïeb, J., Tejpar, S., Wasan, H., Yoshino, T., Zaanan, A., Arnold, D.

Volltext

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR tria... von Gebhart, G., Lamberts, L.E., Wimana, Z., Garcia, C., Emonts, P., Ameye, L., Stroobants, S., Huizing, M., Aftimos, P., Tol, J., Oyen, W.J.G., Vugts, D.J., Hoekstra, O.S., Schröder, C.P., Menke-van der Houven van Oordt, C.W., Guiot, T., Brouwers, A.H., Awada, A., de Vries, E.G.E., Flamen, P.

Volltext

Chemotherapy response evaluation with FDG–PET in patients with colorectal cancer von de Geus-Oei, L.F., van Laarhoven, H. W. M., Visser, E. P., Hermsen, R., van Hoorn, B. A., Kamm, Y. J. L., Krabbe, P. F. M., Corstens, F. H. M., Punt, C. J. A., Oyen, W. J. G.

Volltext

Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer von van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C. T., Dekker, H., van Dongen, G. A. M. S., Vugts, D. J., Boellaard, R., van Herpen, C. M. L., de Vries, E. G. E., Oyen, W. J. G., Brouwers, A. H., Verheul, H. M. W., Hoekstra, O. S., der Houven van Oordt, C. W. Menke-van

Volltext

A systematic review on [18 F]FLT-PET uptake as a measure of treatment response in cancer patients von Bollineni, V.R, Kramer, G.M, Jansma, E.P, Liu, Y, Oyen, W.J.G

Volltext

Long-term global quality of life in patients treated for colorectal liver metastases von Wiering, B., Oyen, W. J. G., Adang, E. M. M., van der Sijp, J. R. M., Roumen, R. M., de Jong, K. P., Ruers, T. J. M., Krabbe, P. F. M.

Volltext

Assessment of mandibular invasion of squamous cell carcinoma by various modes of imaging: constructing a diagnostic algorithm von Van Cann, E.M, Koole, R, Oyen, W.J.G, de Rooy, J.W.J, de Wilde, P.C, Slootweg, P.J, Schipper, M, Merkx, M.A.W, Stoelinga, P.J.W

Volltext

Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery von Wiering, B, Ruers, T J M, Krabbe, P F M, Dekker, H M, Oyen, W J G

Volltext

Biology-guided precision medicine in rare cancers: Lessons from sarcomas and neuroendocrine tumours von van der Graaf, W.T.A., Tesselaar, M.E.T., McVeigh, T.P., Oyen, W.J.G., Fröhling, S.

Volltext

A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats von Aarts, F, Hendriks, T, Boerman, O C, Koppe, M J, Oyen, W J G, Bleichrodt, R P

Volltext

Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach von Heijmen, L., Punt, C. J. A., ter Voert, E. G. W., de Geus-Oei, L. F., Heerschap, A., Bussink, J., Sweep, C. G. J., Zerbi, V., Oyen, W. J. G., Span, P. N., Boerman, O., van Laarhoven, H. W. M.

Volltext

FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma von de Geus-Oei, LF, Wiering, B, Krabbe, PFM, Ruers, TJM, Punt, CJA, Oyen, WJG

Volltext

FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome von Di Fonzo, A, Dekker, M C J, Montagna, P, Baruzzi, A, Yonova, E H, Correia Guedes, L, Szczerbinska, A, Zhao, T, Dubbel-Hulsman, L O M, Wouters, C H, de Graaff, E, Oyen, W J G, Simons, E J, Breedveld, G J, Oostra, B A, Horstink, M W, Bonifati, V

Volltext

Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia von CUIJPERS, M. L. H, VOS, F. J, BLEEKER-ROVERS, C. P, KRABBE, P. F. M, PICKKERS, P, VAN DIJK, A. P. J, WANTEN, G. J. A, STURM, P. D, OYEN, W. J. G, KULLBERG, B. J

Volltext